Dosimetrische Grundlagen für die endovaskuläre Therapie mit Re-188 zur Prävention der Restenose nach Angioplastie Dosimetrie Fundamentals of Endovascular Brachytherapy Using Re-188 to Prevent Restenosis after Angioplasty

Ziel: Für die endovaskuläre Brachytherapie stehen unterschiedliche Radionuklide zur Verfügung. Ein interessantes Konzept ist die Nutzung eines flüssigen Betastrahlers in einem Ballonkatheter. Re-188 kann aus einem Generatorsystem gewonnen werden und steht somit täglich zur Verfügung. Es sollten dosimetrische Daten erhoben werden. Methode: Es wurde die radiale Abnahme der Dosis von Re-188 bei einem typischen Dilatationskatheter (Durchmesser 3 mm, Länge 20 mm) berech- net und mit TLD-Messungen verglichen. Ergebnisse: Bei einer spezifischen Aktivität von 370 MBq/ml konnten 0,3 Gy pro 1 min in 0,5 mm Abstand von der Ballonwand gemessen werden. Doppelmessungen wiesen eine Abweichung von 3% auf. Ein schneller

[1]  F. F. Knapp,et al.  The continuing important role of radionuclide generator systems for nuclear medicine , 1994, European Journal of Nuclear Medicine.

[2]  D. Liermann,et al.  Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries , 2004, CardioVascular and Interventional Radiology.

[3]  H Sack,et al.  [Catheter-based radiotherapy to inhibit restenosis after coronary stenting]. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[4]  F. Knapp,et al.  Elution of Re-188 from W-188/Re-188 generators with salts of weak acids permits efficient concentration to low volumes using a new tandem cation/anion exchange system , 1997 .

[5]  Philippe Nouet,et al.  Feasibility of Intracoronary β-Irradiation to Reduce Restenosis After Balloon Angioplasty A Clinical Pilot Study , 1997 .

[6]  P. Teirstein,et al.  Beta-radiation to reduce restenosis. Too little, too soon? , 1997, Circulation.

[7]  H. Bottcher,et al.  192IR endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience. , 1996, International journal of radiation oncology, biology, physics.

[8]  H. Amols,et al.  Intracoronary irradiation: dose response for the prevention of restenosis in swine. , 1996, International journal of radiation oncology, biology, physics.

[9]  W. Rutishauser,et al.  A novel system for intracoronary beta-irradiation: description and dosimetric results. , 1996, International journal of radiation oncology, biology, physics.

[10]  H. Amols,et al.  Dosimetry of a radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia. , 1996, Medical physics.

[11]  R. Waksman.  Local catheter-based intracoronary radiation therapy for restenosis. , 1996, The American journal of cardiology.

[12]  M. Stabin,et al.  Radiation dose to the wall of blood vessels containing various radionuclides , 1996 .

[13]  D Flühs,et al.  Direct reading measurement of absorbed dose with plastic scintillators--the general concept and applications to ophthalmic plaque dosimetry. , 1996, Medical physics.

[14]  R. Virmani,et al.  Inhibition of neointimal proliferation with low-dose irradiation from a beta-particle-emitting stent. , 1996, Circulation.

[15]  K. Robinson,et al.  Intracoronary low-dose beta-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model. , 1995, Circulation.

[16]  W. Kübler,et al.  Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. , 1995, Circulation.

[17]  W. Rutishauser,et al.  High dose rate brachytherapy for prevention of restenosis after percutaneous transluminal coronary angioplasty: preliminary dosimetric tests of a new source presentation. , 1995, International journal of radiation oncology, biology, physics.

[18]  J Weinberger,et al.  Intracoronary irradiation markedly reduces neointimal proliferation after balloon angioplasty in swine: persistent benefit at 6-month follow-up. , 1995, Journal of the American College of Cardiology.

[19]  D. Duggan,et al.  Low‐Dose, β‐Particle Emission From ‘Stent’ Wire Results in Complete, Localized Inhibition of Smooth Muscle Cell Proliferation , 1994 .

[20]  D. Liermann,et al.  Endovascular irradiation--a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. , 1994, International journal of radiation oncology, biology, physics.

[21]  Rodney A. White.  Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty , 1991 .

[22]  R. Califf,et al.  Restenosis after coronary angioplasty: an overview. , 1991, Journal of the American College of Cardiology.

[23]  K. Karsch,et al.  Morphological Changes and Smooth Muscle Cell Proliferation After Experimental Excimer Laser Treatment , 1991, Circulation.

[24]  C. Ling,et al.  Dose distribution of 125I sources in different tissues. , 1990, Medical physics.

[25]  T. Mackie,et al.  EGS4 Monte Carlo determination of the beta dose kernel in water. , 1990, Medical physics.

[26]  F. Knapp,et al.  Rhenium-188 for therapeutic applications from an alumina-based tungsten-188/rhenium-188 radionuclide generator , 1989 .

[27]  B Meier,et al.  Restenosis after successful coronary angioplasty in patients with single-vessel disease. , 1986, Circulation.

[28]  Persönliche Mitteilung , 1960, 1965.